Dtsch Med Wochenschr 2008; 133(39): 1977-1980
DOI: 10.1055/s-0028-1085606
Aktuelle Diagnostik & Therapie | Review article
Geburtshilfe, Allergologie
© Georg Thieme Verlag KG Stuttgart · New York

Asthma in der Schwangerschaft

Asthma during pregnancyA. Gillissen1 , H. Worth2
  • 1Robert-Koch-Klinik, Thoraxzentrum des Klinikums St. Georg, Leipzig
  • 2Med. Klinik I, Klinikum Fürth
Further Information

Publication History

eingereicht: 14.5.2008

akzeptiert: 11.9.2008

Publication Date:
16 September 2008 (online)

Literatur

  • 1 Alexander S, Dodds L, Armson B A. Perinatal outcomes in women with asthma during pregnancy.  Obstet Gynecol. 1998;  92 435-440
  • 2 Bachert C, Borchard U, Wedi B. et al . Leitlinie der DGAI zur allergischen Rhinokonjunktivitis.  Allergologie. 2003;  26 147-162
  • 3 Blaiss M S. National Institutes of Health . Management of asthma during pregnancy.  Allergy Asthma Proc. 2004;  25 375-379
  • 4 Buhl R. et al . Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.  Pneumologie. 2006;  60 139-183
  • 5 Carlsen K -H, Carlsen K C. Respiratory effects of tobacco smoking on infants and young children.  Paediatr Resp Rev. 2008;  9 11-20
  • 6 Cydulka R K. et al . Acute asthma among pregnant women presenting to the emergency department.  Am J Respir Crit Care Med. 1999;  160 887-892
  • 7 Gillissen A. Die chronisch-obstruktive Lungenerkrankung. Bremen; Uni-Med 2006
  • 8 Gillissen A. Bewertung der Theophyllin-Therapie beim Asthma bronchiale.  Münch Med Wschr. 1997;  139 79-72
  • 9 Gluck J C, Gluck P A. The effects of pregnancy on asthma a prospective study.  Ann Allergy. 1976;  37 164-168
  • 10 Hylkema M N, Sterk P J, de Boer W I, Postma D S. Tobacco use in relation to COPD and asthma.  Eur Respir J. 2007;  29 438-445
  • 11 Jana N. et al . Effect of bronchial asthma on the course of pregnancy, labour and perinatal outcome.  J Obstet Gynaecol. 1995;  21 227-232
  • 12 Källén B. The safety of asthma medications during pregnancy.  Expert Opin Drug Saf. 2007;  6 15-26
  • 13 Källén B, Otterblad Olausson P O. Use of anti-asthmatic drugs during pregnancy. 1. maternal characteristics, pregnancy and delivery complications.  Eur J Clin Pharmacol. 2007;  63 363-373
  • 14 Källén B, Otterblad Olausson P O. Use of anti-asthmatic drugs during pregnancy. 2. infant characteristics excluding congenital malformations.  Eur J Clin Pharmacol. 2007;  63 375-381
  • 15 Källén B, Otterblad Olausson P O. Use of anti-asthmatic drugs during pregnancy. 3. congential malformations in the infants.  Eur J Clin Pharmacol. 2007;  63 383-388
  • 16 Kleine-Tebbe J, Bergmann K -C, Friedrichs F. et al . Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen.  Allergo J. 2006;  15 56-73
  • 17 Koneczny N, Floer B, Isfort J, Vollmar H C, Butzlaff M. Evidenzbasierte Leitlinie zur Asthma Diagnose und Therapie. Asthma Sonderfälle: Schwangere + Kinder. www.evidence.de. 2004
  • 18 Kuczkowksi K M. Te effects of drug abuse on pregnancy.  Curr Opin Obstet Gynecol. 2007;  19 578-585
  • 19 Kwon H L, Belanger K, Bracken M B. Asthma prevalence among pregnant and child bearing-aged women in the United States: estimates from national health surveys.  Ann Epidemiol. 2003;  13 317-324
  • 20 Lumley J, Oliver S S, Chamberlain C, Oakley L. Internventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2004 CD001055
  • 21 Mabie W C, Barton J R, Wasserstrum N, Sibai B M. Clinical observations on asthma and pregnancy.  J Matern Fetal Med. 1992;  1 45-50
  • 22 Mann R D. Salmeterol: a study by prescription-event monitoring in a UK cohort of 15 407 patients.  J Clin Epidemiol. 1996;  49 247-250
  • 23 Murphy V E, Gibson P G, Smith R, Clifton V L. Asthma during pregenancy: mechanisms and treatment implications.  Eur Respir J. 2005;  25 731-750
  • 24 National Institutes of Health (Hrsg) .Global strategy for asthma management and prevention NHLBI/WHO Workshop report. Bethesda, USA; U.S. Department of Health and Human Services 2006: 1-176 (www.ginasthma.com)
  • 25 Park-Wyllie L, Mazzotta P, Pastuszak A. et al . Birth defects after maternal exposure to corticosteroids.  Teratology. 2000;  62 385-392
  • 26 Salihu H M, Wilson R E. Epidemiology of prenatal smoking and perinatal outcomes.  Early Hum Dev. 2007;  83 713-720
  • 27 Schatz M. Interrelationships between asthma and pregnancy: a literature review.  J Allergy Clin Immunol. 1999;  103 330-336
  • 28 Schatz M. et al . The safety of asthma and allergy medications during pregnancy.  J Allergy Clin Immunol. 2008;  100 301-306
  • 29 Shanies H M, Venkataraman M T, Peter T. Reversal of intractable acute severe asthma by first-trimester termination of pregnancy.  J Asthma. 1997;  34 169-172
  • 30 Suissa S. et al . Low-dose inhaled corticosteroids and the prevention of death from asthma.  N Engl J Med. 2000;  343 332-336
  • 31 U.S.Department of Health and Human Services, National Institutes of Health .National asthma education and prevention program. Working group report on managing asthma during pregnancy: recommendations for pharmacologic treatment. Update 2004/2005. http://www.nhlbi.nih.gov
  • 32 U.S.Food and Drug Administration . U.S. FDA labeling and prescription drug advertising: content and format for labeling for human prescriptions drugs.  Fed Regist. 1979;  44 37434-37467
  • 33 Worth H, Butt U, Wettengel R. Empfehlung zur Behandlung von Asthma in der Schwangerschaft.  Med Klin. 1996;  91 435-437

Prof. Dr. A. Gillissen

Robert-Koch-Klinik, Thoraxzentrum des Klinikums St. Georg

Nikolai-Rumjanzew-Str. 100

04207 Leipzig

Phone: 0341/4231-202

Fax: 0341/4231-203

URL: http://www.rkk-leipzig.de

    >